{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:17:26Z","timestamp":1771373846711,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Susan G. Komen Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>The increase in breast cancer risk during pregnancy and postpartum is well known; however, the molecular phenotype of breast cancers occurring shortly after pregnancy has not been well studied. Given this, we investigated whether nulliparity and the time interval since pregnancy among parous women affects the breast cancer phenotype in young women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods.<\/jats:title>\n                  <jats:p>We examined molecular phenotype in relation to time since pregnancy in a prospective cohort of 707 young women (aged \u226440 years) with breast cancer. Parity was ascertained from study questionnaires. Using tumor histologic grade on central review and biomarker expression, cancers were categorized as luminal A- or B-like, HER2 enriched, and triple negative.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Overall, 32% were luminal A-like, 41% were luminal B-like, 9% were HER2 enriched, and 18% were triple negative. Although, numerically, patients diagnosed &amp;gt;5 years after pregnancy had more luminal A-like subtypes than women with shorter intervals since pregnancy, there was no evidence of a relationship between these intervals and molecular subtypes once family history of breast cancer and age at diagnosis were considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Distribution of breast cancer molecular phenotype did not differ significantly among young women by parity or time interval since parturition when important predictors of tumor phenotype such as age and family history were considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice:<\/jats:title>\n                  <jats:p>Distribution of breast cancer molecular phenotype did not differ among parous young women by time interval since pregnancy. The implication of these findings for clinical practice suggests that pregnancy-associated breast cancers may be seen up to 5 years beyond parturition.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2014-0412","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T02:56:04Z","timestamp":1432954564000},"page":"713-718","source":"Crossref","is-referenced-by-count":20,"title":["Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women"],"prefix":"10.1093","volume":"20","author":[{"given":"Laura C.","family":"Collins","sequence":"first","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA;"},{"name":"Harvard Medical School, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Gelber","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Marotti","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"White","sequence":"additional","affiliation":[{"name":"University Hospitals Case Medical Center, Cleveland, Ohio, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Ruddy","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena F.","family":"Brachtel","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA;"},{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Schapira","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA;"},{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Come","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA;"},{"name":"Harvard Medical School, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia F.","family":"Borges","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center, Aurora, Colorado, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepper","family":"Schedin","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland, Oregon, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Warner","sequence":"additional","affiliation":[{"name":"Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Wensley","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA;"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA;"},{"name":"Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"},{"name":"Harvard Medical School, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"},{"name":"Harvard Medical School, Boston, Massachusetts, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"2021122309372624100_B1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6602302","article-title":"Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects","volume":"92","author":"Albrektsen","year":"2005","journal-title":"Br J Cancer"},{"key":"2021122309372624100_B2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.297.6656.1096","article-title":"Short term increase in risk of breast cancer after full term pregnancy","volume":"297","author":"Bruzzi","year":"1988","journal-title":"BMJ"},{"key":"2021122309372624100_B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199407073310102","article-title":"Transient increase in the risk of breast cancer after giving birth","volume":"331","author":"Lambe","year":"1994","journal-title":"N Engl J Med"},{"issue":"(suppl)","key":"2021122309372624100_B4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8","article-title":"Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06","volume":"91","author":"Fisher","year":"2001","journal-title":"Cancer"},{"key":"2021122309372624100_B5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1072-7515(00)00257-X","article-title":"Stage 0 to stage III breast cancer in young women","volume":"190","author":"Gajdos","year":"2000","journal-title":"J Am Coll Surg"},{"key":"2021122309372624100_B6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-4-82","article-title":"Young age: an independent risk factor for disease-free survival in women with operable breast cancer","volume":"4","author":"Han","year":"2004","journal-title":"BMC Cancer"},{"key":"2021122309372624100_B7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancer: population based study","volume":"320","author":"Kroman","year":"2000","journal-title":"BMJ"},{"key":"2021122309372624100_B8","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ejca.2005.02.029","article-title":"Survival of young and older breast cancer patients in Geneva from 1990 to 2001","volume":"41","author":"Rapiti","year":"2005","journal-title":"Eur J Cancer"},{"key":"2021122309372624100_B9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198608283150906","article-title":"The relation between survival and age at diagnosis in breast cancer","volume":"315","author":"Adami","year":"1986","journal-title":"N Engl J Med"},{"key":"2021122309372624100_B10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U","article-title":"Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group","volume":"72","author":"Bonnier","year":"1997","journal-title":"Int J Cancer"},{"key":"2021122309372624100_B11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00001648-199811000-00019","article-title":"Relation of time since last birth and parity to survival of young women with breast cancer","volume":"9","author":"Olson","year":"1998","journal-title":"Epidemiology"},{"key":"2021122309372624100_B12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-013-2522-1","article-title":"Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)","volume":"139","author":"Johansson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2021122309372624100_B13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"2021122309372624100_B14","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122309372624100_B15","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122309372624100_B16","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","article-title":"Molecular classification and molecular forecasting of breast cancer: ready for clinical application?","volume":"23","author":"Brenton","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122309372624100_B17","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"2021122309372624100_B18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1590\/S1807-59322010001000019","article-title":"Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients","volume":"65","author":"Carvalho","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"issue":"(suppl 1s)","key":"2021122309372624100_B19","first-page":"26A","article-title":"Breast cancer in Mexican women younger than age 45 years. A clinicopathologic study of 1,320 cases","volume":"24","author":"Alvarado-Cabrero","year":"2011","journal-title":"Mod Pathol"},{"key":"2021122309372624100_B20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","article-title":"Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer","volume":"131","author":"Collins","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2021122309372624100_B21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1245\/s10434-011-2104-6","article-title":"Association between recency of last pregnancy and biologic subtype of breast cancer","volume":"19","author":"Pilewskie","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2021122309372624100_B22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-013-2437-x","article-title":"Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer","volume":"138","author":"Callihan","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2021122309372624100_B23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10549-013-2507-0","article-title":"Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women","volume":"138","author":"Nagatsuma","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2021122309372624100_B24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1755-8794-5-46","article-title":"Defining the genomic signature of the parous breast","volume":"5","author":"Peri","year":"2012","journal-title":"BMC Med Genomics"},{"key":"2021122309372624100_B25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1055-9965.EPI-07-0678","article-title":"Full-term pregnancy induces a specific genomic signature in the human breast","volume":"17","author":"Russo","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021122309372624100_B26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1940-6207.CAPR-09-0069","article-title":"Gene expression patterns in the human breast after pregnancy","volume":"3","author":"Asztalos","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"2021122309372624100_B27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2021122309372624100_B28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2021122309372624100_B29","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi","year":"2008","journal-title":"Breast Cancer Res"},{"key":"2021122309372624100_B30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/1055-9965.EPI-06-0806","article-title":"Differences in risk factors for breast cancer molecular subtypes in a population-based study","volume":"16","author":"Yang","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021122309372624100_B31","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2021122309372624100_B32","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"2021122309372624100_B33","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr3556","article-title":"Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women","volume":"15","author":"Keegan","year":"2013","journal-title":"Breast Cancer Res"},{"key":"2021122309372624100_B34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1634\/theoncologist.2011-0469","article-title":"The effect of age on delay in diagnosis and stage of breast cancer","volume":"17","author":"Partridge","year":"2012","journal-title":"The Oncologist"},{"key":"2021122309372624100_B35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10911-009-9119-7","article-title":"Pregnancy and breast cancer: when they collide","volume":"14","author":"Lyons","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2021122309372624100_B36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/88.6.359","article-title":"Nurses\u2019 health study: log-incidence mathematical model of breast cancer incidence","volume":"88","author":"Rosner","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"2021122309372624100_B37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc1839","article-title":"Pregnancy-associated breast cancer and metastasis","volume":"6","author":"Schedin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2021122309372624100_B38","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122309372624100_B39","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nm.2416","article-title":"Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2","volume":"17","author":"Lyons","year":"2011","journal-title":"Nat Med"},{"key":"2021122309372624100_B40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djh025","article-title":"Risk factors for breast cancer according to estrogen and progesterone receptor status","volume":"96","author":"Colditz","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2021122309372624100_B41","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"Anders","year":"2008","journal-title":"J Clin Oncol"},{"key":"2021122309372624100_B42","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1200\/JCO.2006.10.3754","article-title":"Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea\u2014a report from the Korean Breast Cancer Society","volume":"25","author":"Ahn","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122309372624100_B43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdf039","article-title":"Very young women (&lt;35 years) with operable breast cancer: features of disease at presentation","volume":"13","author":"Colleoni","year":"2002","journal-title":"Ann Oncol"},{"key":"2021122309372624100_B44","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/bcr3156","article-title":"Occurrence of breast cancer subtypes in adolescent and young adult women","volume":"14","author":"Keegan","year":"2012","journal-title":"Breast Cancer Res"},{"key":"2021122309372624100_B45","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","article-title":"Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2021122309372624100_B46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12253-011-9381-z","article-title":"Female breast cancer status according to ER, PR and HER2 expression: a population based analysis","volume":"17","author":"Caldarella","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"2021122309372624100_B47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma","volume":"19","author":"Livasy","year":"2006","journal-title":"Mod Pathol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2014-0412","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2014-0412","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/20\/7\/713\/41870647\/oncolo_20_7_713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/20\/7\/713\/41870647\/oncolo_20_7_713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T03:42:05Z","timestamp":1640317325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/20\/7\/713\/6399306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,5,29]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2014-0412","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,7,1]]},"published":{"date-parts":[[2015,5,29]]}}}